The selection of echocardiographic indexes for efficacy evaluation of heart failure with preserved ejection fraction (HFpEF) lacks a uniform standard.

Analyze the echocardiographic outcome measures in randomized controlled trials (RCT) of HFpEF to provide a reference for the development of a standardized efficacy evaluation system for HFpEF.

PubMed, Embase and Cochrane Central Register of Controlled Trials were searched for RCT related to HFpEF from January 1, 2021 to November 3, 2023. Echocardiographic outcome measures and other information were extracted after literature screening according to eligibility criteria. The frequency and percentage of echocardiographic outcome measures were analyzed and an association rule analysis was conducted.

A total of 825 literatures were obtained and 14 literatures were finally included after screening. A total of 39 echocardiographic outcome measures were used in 14 studies. The minimum number of echocardiographic outcome measures used in a single study was 2, and the maximum was 18. The top 10 echocardiographic outcome measures in terms of usage frequency were ratio of mitral peak velocity of early filling (E) to mitral peak velocity of late filling (A), left ventricular ejection fraction (LVEF), average ratio of E to early diastolic mitral annular velocity (e'), left atrial volume index (LAVI), left ventricular end-diastolic diameter (LVEDD), left atrial diameter (LAD), septal E/e', left ventricular mass index (LVMI), E deceleration time (EDT) and tricuspid annular plane systolic excursion (TAPSE). The association rule analysis showed that when different quantitative indicators were combined, the rules with the highest support were respectively average E/e'→LAVI, LVEF+E/A→LVEDD and LAVI+average E/e'+LVEF→LVEDD.

In HFpEF RCT, the commonly used echocardiographic outcome measures are E/A, LVEF, and average E/e'. Moreover, LAVI and LVEDD are often used in combination with the above indicators. Lack of consistency, rationality, recognition and standardization are the problems of echocardiographic outcome measures selection in HFpEF RCT. The development of a core outcome set may be an effective way to solve the above problems.

射血分数保留型心力衰竭（HFpEF）超声心动图疗效评价指标的选择缺乏统一标准。

分析HFpEF随机对照试验（RCT）中的超声心动图结局指标，为HFpEF标准化疗效评价体系的构建提供参考。

检索PubMed、Embase和Cochrane Central Register of Controlled Trials数据库中与HFpEF相关的RCT，时间为2021-01-01—2023-11-03。根据纳入、排除标准筛选文献后提取超声心动图结局指标等信息。统计超声心动图结局指标的频次、频率并进行关联规则分析。

共检索到825篇文献，经筛选最终纳入14篇文献。14篇文献共使用39个超声心动图结局指标，单项研究最少使用2个，最多使用18个。使用频次排名前10的指标为舒张早期左房室瓣血流速度峰值（E）/舒张晚期左房室瓣血流速度峰值（A）、左心室射血分数（LVEF）、平均E/舒张早期左房室瓣环组织运动速度峰值（e'）、左心房容积指数（LAVI）、左心室舒张末期内径（LVEDD）、左心房内径（LAD）、间隔E/e'、左心室质量指数（LVMI）、E峰减速时间（EDT）、右房室瓣环收缩期位移（TAPSE）。关联规则分析显示，不同数量指标组合时条件支持度最高的规则分别为平均E/e'→LAVI、LVEF+E/A→LVEDD、LAVI+平均E/e'+LVEF→LVEDD。

HFpEF RCT中常用的超声心动图结局指标有E/A、LVEF和平均E/e'，LAVI、LVEDD常与以上指标组合使用。HFpEF RCT中超声心动图结局指标的选择存在不一致、不合理、不公认、不规范的问题，建立核心指标集可能是解决上述问题的有效方法。